skip to main content

Methylphenidate monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCNS TherapeuticsMethylphenidate monitoringGPhC CRA

A mother brings in a prescription for methylphenidate modified-release capsules for her 8-year-old son who has recently been diagnosed with ADHD. She is concerned about the medication. What is the most important monitoring requirement she should be aware of?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Height, weight, heart rate, and blood pressure should be monitored regularly during treatment

Methylphenidate can suppress appetite and growth, and can increase heart rate and blood pressure. NICE recommends monitoring height, weight, heart rate, and blood pressure at baseline, after each dose adjustment, and at least every six months during treatment. Growth should be plotted on centile charts. An ECG is not routinely required unless there is a cardiac history or examination findings, but cardiovascular monitoring through pulse and blood pressure is essential.

Reference: BNF; NICE NG87 ADHD